CS228536B2 - Production method of 3-aryl-5-isothiazole - Google Patents
Production method of 3-aryl-5-isothiazole Download PDFInfo
- Publication number
- CS228536B2 CS228536B2 CS816978A CS697881A CS228536B2 CS 228536 B2 CS228536 B2 CS 228536B2 CS 816978 A CS816978 A CS 816978A CS 697881 A CS697881 A CS 697881A CS 228536 B2 CS228536 B2 CS 228536B2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- acid
- amino
- formula
- methyl
- analysis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physical Education & Sports Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/189,435 US4346094A (en) | 1980-09-22 | 1980-09-22 | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CS228536B2 true CS228536B2 (en) | 1984-05-14 |
Family
ID=22697314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CS816978A CS228536B2 (en) | 1980-09-22 | 1981-09-22 | Production method of 3-aryl-5-isothiazole |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4346094A (ro) |
| EP (1) | EP0048615B1 (ro) |
| JP (1) | JPS5785379A (ro) |
| KR (1) | KR830007597A (ro) |
| AR (1) | AR229103A1 (ro) |
| AT (1) | ATE7657T1 (ro) |
| AU (1) | AU7551681A (ro) |
| CS (1) | CS228536B2 (ro) |
| DD (1) | DD201790A5 (ro) |
| DE (1) | DE3163900D1 (ro) |
| DK (1) | DK417981A (ro) |
| ES (1) | ES505678A0 (ro) |
| FI (1) | FI812940L (ro) |
| GB (1) | GB2084573B (ro) |
| GR (1) | GR75046B (ro) |
| IL (1) | IL63890A0 (ro) |
| NO (1) | NO813208L (ro) |
| PL (1) | PL130497B1 (ro) |
| PT (1) | PT73711B (ro) |
| RO (1) | RO82216A (ro) |
| YU (1) | YU227181A (ro) |
| ZA (1) | ZA816549B (ro) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4428956A (en) | 1980-12-29 | 1984-01-31 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4431652A (en) * | 1980-12-29 | 1984-02-14 | Merck & Co., Inc. | 4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis |
| US4539328A (en) * | 1983-03-25 | 1985-09-03 | Fmc Corporation | Nematicidal isothiazole derivatives |
| US4620865A (en) * | 1983-11-07 | 1986-11-04 | Eli Lilly And Company | Herbicidal and algicidal 1,5-disubstituted-1H-pyrazole-4-carboxamides |
| IE59813B1 (en) * | 1986-05-09 | 1994-04-06 | Warner Lambert Co | Styryl pyrazoles, isoxazoles and analogs thereof having activity as 5-lipoxy-genase inhibitors and pharmaceutical compositions containing them |
| ZW21687A1 (en) * | 1986-12-12 | 1988-07-20 | Hoffmann La Roche | Triazine derivatives |
| DE69122084T2 (de) * | 1990-11-30 | 1997-04-03 | Teijin Ltd., Osaka | 2-arylthiazolderivat sowie dieses enthaltendes arzneimittel |
| US5294630A (en) * | 1992-07-07 | 1994-03-15 | Eli Lilly And Company | Treatment of inflammatory bowel disease |
| US5436258A (en) * | 1992-09-09 | 1995-07-25 | Eli Lilly And Company | Prevention of bone resorption |
| MY117352A (en) * | 1995-10-31 | 2004-06-30 | Ciba Sc Holding Ag | Oximesulfonic acid esters and the use thereof as latent sulfonic acids. |
| ID21775A (id) * | 1996-10-25 | 1999-07-22 | Yoshitomi Pharmaceutical | Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya |
| AU1520699A (en) | 1997-11-07 | 1999-05-31 | Johns Hopkins University, The | Methods for treatment of disorders of cardiac contractility |
| TW575792B (en) * | 1998-08-19 | 2004-02-11 | Ciba Sc Holding Ag | New unsaturated oxime derivatives and the use thereof as latent acids |
| SG78412A1 (en) | 1999-03-31 | 2001-02-20 | Ciba Sc Holding Ag | Oxime derivatives and the use thereof as latent acids |
| JP2005517026A (ja) | 2002-02-06 | 2005-06-09 | チバ スペシャルティ ケミカルズ ホールディング インコーポレーテッド | スルホナート誘導体及び潜酸としてのその使用 |
| ATE440820T1 (de) * | 2004-08-27 | 2009-09-15 | Astellas Pharma Inc | 2-phenylpyridinderivat |
| JPWO2006022375A1 (ja) * | 2004-08-27 | 2008-05-08 | アステラス製薬株式会社 | ２−フェニルチオフェン誘導体 |
| WO2007043457A1 (ja) | 2005-10-07 | 2007-04-19 | Astellas Pharma Inc. | トリアリールカルボン酸誘導体 |
| CA2643272A1 (en) | 2006-02-24 | 2007-08-30 | Astellas Pharma Inc. | Gent for treating or preventing digestive ulcer |
| GB2450975B (en) | 2007-07-12 | 2010-02-24 | Ciba Holding Inc | Yellow radiation curing inks |
| ES2526930T3 (es) * | 2008-05-22 | 2015-01-16 | Astrazeneca Ab | Método para el tratamiento de la hiperuricemia empleando un inhibidor de SGLT2 y composición que contiene el mismo |
| KR101639834B1 (ko) | 2009-02-27 | 2016-07-14 | 데이진 화-마 가부시키가이샤 | 천이 금속 촉매를 사용한 커플링법에 의한 페닐 치환 복소 고리 유도체의 제조법 |
| JP2012522084A (ja) | 2009-03-30 | 2012-09-20 | ビーエーエスエフ ソシエタス・ヨーロピア | Ｕｖ線量インジケータフィルム |
| KR101800054B1 (ko) | 2010-08-27 | 2017-11-21 | 데이진 화-마 가부시키가이샤 | 팔라듐 화합물을 사용한 커플링법에 의한 페닐 치환 복소 고리 유도체의 제조법 |
| KR101897842B1 (ko) | 2011-01-28 | 2018-09-12 | 바스프 에스이 | 열 경화제로서 옥심 술포네이트를 포함하는 중합성 조성물 |
| PT2980085T (pt) | 2013-03-29 | 2018-04-09 | Teijin Pharma Ltd | Compostos farmaceuticamente activos |
| WO2016030790A1 (en) | 2014-08-29 | 2016-03-03 | Basf Se | Oxime sulfonate derivatives |
| EP3288893B8 (de) | 2015-04-29 | 2019-04-10 | BSN medical GmbH | Mehrstufiges verfahren zur no-herstellung |
| EP3288517B1 (de) | 2015-04-29 | 2019-07-17 | BSN Medical GmbH | Medizinische badevorrichtung |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1178604A (en) * | 1966-03-21 | 1970-01-21 | American Cyanamid Co | Novel Pyridinium Salts and Methods for Preparing Same |
| US3464999A (en) * | 1967-07-27 | 1969-09-02 | R & L Molecular Research Ltd | Thiadiazolylisothiazoles |
| GB1180268A (en) * | 1967-09-26 | 1970-02-04 | Ici Ltd | Pharmaceutically Active Phenyl-Heterocyclic-Alkanol Derivatives |
| GB1192701A (en) * | 1968-03-22 | 1970-05-20 | Ici Ltd | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same |
| US3681498A (en) * | 1970-10-19 | 1972-08-01 | American Cyanamid Co | Isothiazolyl pyridinium salts as hypoglycemic agents |
-
1980
- 1980-09-22 US US06/189,435 patent/US4346094A/en not_active Expired - Lifetime
-
1981
- 1981-09-19 PL PL1981233103A patent/PL130497B1/pl unknown
- 1981-09-20 IL IL63890A patent/IL63890A0/xx unknown
- 1981-09-21 GR GR66108A patent/GR75046B/el unknown
- 1981-09-21 ZA ZA816549A patent/ZA816549B/xx unknown
- 1981-09-21 YU YU02271/81A patent/YU227181A/xx unknown
- 1981-09-21 AU AU75516/81A patent/AU7551681A/en not_active Abandoned
- 1981-09-21 AT AT81304325T patent/ATE7657T1/de not_active IP Right Cessation
- 1981-09-21 DE DE8181304325T patent/DE3163900D1/de not_active Expired
- 1981-09-21 FI FI812940A patent/FI812940L/fi not_active Application Discontinuation
- 1981-09-21 PT PT73711A patent/PT73711B/pt unknown
- 1981-09-21 NO NO813208A patent/NO813208L/no unknown
- 1981-09-21 RO RO81105346A patent/RO82216A/ro unknown
- 1981-09-21 ES ES505678A patent/ES505678A0/es active Granted
- 1981-09-21 DK DK417981A patent/DK417981A/da not_active Application Discontinuation
- 1981-09-21 AR AR286818A patent/AR229103A1/es active
- 1981-09-21 EP EP81304325A patent/EP0048615B1/en not_active Expired
- 1981-09-21 GB GB8128465A patent/GB2084573B/en not_active Expired
- 1981-09-22 KR KR1019810003537A patent/KR830007597A/ko not_active Abandoned
- 1981-09-22 DD DD81233487A patent/DD201790A5/de unknown
- 1981-09-22 JP JP56150483A patent/JPS5785379A/ja active Pending
- 1981-09-22 CS CS816978A patent/CS228536B2/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| FI812940A7 (fi) | 1982-03-23 |
| PT73711A (en) | 1981-10-01 |
| EP0048615A1 (en) | 1982-03-31 |
| GB2084573B (en) | 1984-09-12 |
| PT73711B (en) | 1982-12-20 |
| ATE7657T1 (de) | 1984-06-15 |
| FI812940L (fi) | 1982-03-23 |
| US4346094A (en) | 1982-08-24 |
| ES8301225A1 (es) | 1982-12-01 |
| RO82216A (ro) | 1983-07-07 |
| PL233103A1 (ro) | 1982-12-20 |
| DK417981A (da) | 1982-03-23 |
| PL130497B1 (en) | 1984-08-31 |
| AU7551681A (en) | 1982-04-01 |
| DE3163900D1 (en) | 1984-07-05 |
| GR75046B (ro) | 1984-07-12 |
| RO82216B (ro) | 1983-06-30 |
| IL63890A0 (en) | 1981-12-31 |
| AR229103A1 (es) | 1983-06-15 |
| JPS5785379A (en) | 1982-05-28 |
| YU227181A (en) | 1983-10-31 |
| KR830007597A (ko) | 1983-11-04 |
| EP0048615B1 (en) | 1984-05-30 |
| DD201790A5 (de) | 1983-08-10 |
| GB2084573A (en) | 1982-04-15 |
| ES505678A0 (es) | 1982-12-01 |
| NO813208L (no) | 1982-03-23 |
| ZA816549B (en) | 1983-04-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CS228536B2 (en) | Production method of 3-aryl-5-isothiazole | |
| US5596013A (en) | Dihydro pyrazolopyrroles | |
| EP0730588B1 (en) | Isoxazoline compounds as antiinflammatory agents | |
| US5459151A (en) | N-acyl substituted phenyl piperidines as bronchodilators and antiinflammatory agents | |
| TW316904B (ro) | ||
| US4495195A (en) | Xanthine oxidase inhibiting 3(5)-phenyl-substituted-5(3)-pyrazole-carboxylic acid derivatives, compositions, and methods of use | |
| RU2184731C2 (ru) | Амиды аминотиофенкарбоновой кислоты, способ их получения (варианты) и фармацевтическая композиция | |
| AU684887B2 (en) | Isoxazoline compounds as inhibitors of TNF release | |
| US5011849A (en) | Compounds for treating and preventing cognitive diseases and depression and methods of making same | |
| EP0342682A2 (en) | Hydroxamate derivatives of selected nonsteroidal anti-inflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition | |
| US6469003B1 (en) | Pyridazinone derivatives | |
| JP2001354563A (ja) | 置換ベンジルアミン類を含有する医薬 | |
| US5204482A (en) | Compounds for treating and preventing cognitive diseases and depression and methods of making same | |
| US5112868A (en) | Hydroxamate derivatives of selected nonsteroidal antiinflammatory acyl residues having cyclooxygenase and 5-lipoxygenase inhibition | |
| US4652565A (en) | Piperazine derivatives, their production and pharmaceutical compositions containing them | |
| US4544752A (en) | 3-Aryl-5-isothiazolecarboxylic acids and related compounds used to lower uric acid levels | |
| US5250700A (en) | Phenyl pyrazolidinones as bronchodilators and anti-inflammatory agents | |
| US5418236A (en) | Anxiolytic aroyl piperidinyl and piperazinylacyl pyrroles | |
| US4935434A (en) | Antiarthritic isoxazole-4-carboxamides | |
| US4588725A (en) | 2-piperazinyl-quinazoline derivatives and pharmaceutical compositions containing them | |
| PT92507B (pt) | Processo para a preparacao de alfa-ciano-beta-oxopropionamidas | |
| BRPI0618131A2 (pt) | derivado de alquilcarbamoil naftalenilóxi-octenoilidroxiamida tendo atividade inibitória contra histona desacetilase e sua preparação | |
| US4563452A (en) | Derivatives of oxazinobenzothiazine-6,6-dioxide | |
| JP4629105B2 (ja) | Ｍａｏｂインヒビターとしてのベンジルオキシ誘導体 | |
| EP0502110B1 (fr) | Derives d'(hetero) arylmethyloxy-4 phenyl diazole, leur procede de preparation et leur application en therapeutique |